Le Lézard
Classified in: Health
Subject: MAT

Red Spot Interactive Recognizes Top Plastic Surgery Practices for Patient Engagement


JUPITER, Fla., June 14, 2018 /PRNewswire-PRWeb/ -- Red Spot Interactive announced the most recent plastic surgery practice recipients of the Excellence in Patient Engagement & Practice Management Award?Adam J. Rubinstein, MD, FACS of Miami, Florida and John W. Decorato, MD, FACS of Staten Island, New York.

Jason Tuschman, the CEO and Founder of Red Spot Interactive, expresses his elation, "These practices have been able to maintain the highest levels of patient satisfaction in a consumer-driven market while being able to acquire and retain patients in the most effective manner possible. They are true industry leaders."

"The experience we provide to our patients is of the utmost importance at my practice. The team works extremely hard to provide exceptional customer service; we are dedicated to making sure the patient is engaged and happy about their experience and treatment. Working with Red Spot Interactive has helped us to acquire and retain patients at the highest levels possible while constantly improving our patient engagement and practice's ability to scale profitably," stated Dr. Rubinstein of Adam J. Rubinstein, MD, FACS.

"We strive to provide plastic surgery services and treatments in a professional and caring manner. Our patients and their experience are our top concerns. Working with RSI has allowed our practice to fully focus on these top priorities, while RSI expedites and supports the process associated with patient acquisition and retention," commented Dr. Decorato of John W. Decorato, MD, FACS.

Red Spot Interactive's platform was built with elective healthcare practices in mind. The company's technology is driven by their clients return on investment from patient acquisition and retention. Plastic surgeon marketing effectiveness is simplified through easy to use return on investment analytics regarding marketing and patient acquisition. The technology is accompanied by professional services, regarding practice marketing and a patient scheduling call center, which significantly reduces the workload associated with these time consuming tasks.

About Adam J. Rubinstein, MD, FACS
Located in Miami, FL, Adam J. Rubinstein, MD, FACS is a Miami plastic surgeon who has been practicing for over 15 years in south Florida. Dr. Rubinstein is board certified by the American Board of Plastic Surgery and provides a fully certified operating room out of his facility, allowing him to provide an exceptional patient experience.

About John W. Decorato, MD, FACS
Located in Staten Island, NY, John W. Decorato, MD, FACS is a state-of-the-art facility run by Dr. Decorato, one of Staten Island's top plastic surgeons. Board certified by the American Board of Plastic Surgery, Dr. Decorato is recognized as a highly educated and skilled plastic surgeon offering personalized and professional care and services to his patients.

About Red Spot Interactive
Red Spot Interactive provides end to end patient acquisition technology and services for plastic surgeons, dermatologists, opthamologists, and orthodontists. Plastic surgery marketing is simplified and optimized through detailed return on investment reporting and analytics of the entire patient acquisition process. Through the proprietary integration of practice management, EMR, and marketing data, Red Spot Interactive is able to understand, automate, and improve its clients' ROI associated with the patient acquisition and retention process.

 

SOURCE Red Spot Interactive


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: